Trial intelligence / Profile preview

Rosuvastatin in SSc-related Pulmonary Hypertension

NCT00984932Phase 3Completed

Sponsor
Alexandria University
Start
Sep 2008
Primary completion
Jul 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of rosuvastatin in pulmonary arterial hypertension (PAH), sponsored by Alexandria University. Started Sep 2008; status: completed.

02

Drugs

rosuvastatin
03

Conditions

pulmonary arterial hypertension (PAH)

Beyond the preview

Go deeper on NCT00984932.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00984932.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call